European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

European Joint Programme on Rare Diseases

Description du projet

Un écosystème durable pour améliorer la vie des patients atteints de maladies rares

La recherche sur les maladies rares (MR) reste fragmentée en Europe, entraînant des retards dans le diagnostic, moins de médicaments et un accès limité aux soins. Ce domaine de recherche pourrait considérablement profiter d’une meilleure coordination en Europe et au-delà. Le projet EJP RD, cofinancé par l’UE, (130 instituts, 35 pays) développe un écosystème de recherche RD efficace pour aborder ce problème. Il améliore l’intégration, l’efficacité et l’impact social de la recherche RD en développant, démontrant et promouvant la recherche en Europe/dans le monde, et en partageant les données cliniques, les ressources, les procédures, les connaissances et l’expertise. En outre, il mène et développe un modèle de soutien financier efficace pour tous les types de recherche RD associés à l’exploitation accélérée des résultats de recherche qui profitera aux patients.

Objectif

As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profit from coordination on a European and international scale. RD research should be improved to overcome fragmentation, leading to efficacious use of data and resources, faster scientific progress and competitiveness, and most importantly to decrease unnecessary hardship and prolonged suffering of RD patients. In the specific context of the massive generation, need for reuse and efficient interpretation of data, introduction of omics into care practice and the structuration of RD care centers in European Reference Networks, it appears crucial and timely to maximize the potential of already funded tools and programmes by supporting them further, scaling up, linking, and most importantly, adapting them to the needs of end-users through implementation tests in real settings. Such a concerted effort is necessary to develop a sustainable ecosystem allowing a virtuous circle between RD care, research and medical innovation. To achieve this goal, the European Joint Programme on RD (EJP RD) has two major objectives: (i) To improve the integration, the efficacy, the production and the social impact of research on RD through the development, demonstration and promotion of Europe/world-wide sharing of research and clinical data, materials, processes, knowledge and know-how; (ii) To implement and further develop an efficient model of financial support for all types of research on RD (fundamental, clinical, epidemiological, social, economic, health service) coupled with accelerated exploitation of research results for benefit of patients. To this end, the EJP RD actions will be organized within four major Pillars assisted by the central coordination: (P1): Funding of research; (P2): Coordinated access to data and services; (P3) Capacity building; (P4): Accelerated translation of research projects and improvement outcomes of clinical studies.

Appel à propositions

H2020-SC1-BHC-2018-2020

Voir d’autres projets de cet appel

Sous appel

H2020-SC1-2018-Single-Stage-RTD

Coordinateur

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Contribution nette de l'UE
€ 7 784 500,15
Adresse
RUE DE TOLBIAC 101
75654 Paris
France

Voir sur la carte

Région
Ile-de-France Ile-de-France Paris
Type d’activité
Research Organisations
Liens
Coût total
€ 13 469 759,58

Participants (156)